MENU
LRMR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Larimar Therapeutics (LRMR) Earnings Date & Reports

A.I. Advisor
published Earnings

LRMR is expected to report earnings to rise 28.50% to -30 cents per share on March 12

Larimar Therapeutics LRMR Stock Earnings Reports
Q4'24
Est.
$-0.31
Q3'24
Beat
by $0.13
Q2'24
Missed
by $0.03
Q1'24
Missed
by $0.03
Q4'23
Missed
by $0.05
The last earnings report on October 30 showed earnings per share of -23 cents, beating the estimate of -37 cents. With 197.41K shares outstanding, the current market capitalization sits at 252.67M.
View a ticker or compare two or three
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which engages in the research and development of a therapeutic treatment for mitochondrial disorders and Friedreich's ataxia

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Three Bala Plaza East
Phone
+1 844 511-9056
Employees
42
Web
https://www.larimartx.com